The average maximum dose of semaglutide was 0.77 mg, and all participants with a reported weight at week 64 lost over 5% of their body weight, and 85.3% lost over 10% of their baseline body weight.

Mounting demand for Novo Nordisk-made Ozempic and Wegovy has fueled a rise of illegal sales of the weight-loss drugs in Denmark, where the pharma giant is based, the Danish Medicines Agency reported.

Semaglutide So Effective at Treating Arthritis That Patients Were “More or Less Were Treated Out of the Study ... who works at the Copenhagen University Hospital in Denmark's capital.

People who lost a significant amount of weight with semaglutide saw major improvements in osteoarthritis knee pain, ... a professor of rheumatology at the University of Copenhagen in Denmark. ...

The real-world cohort study involved 2,246 individuals in Denmark (79% female, median age 49 years, median BMI of 33.2, median body weight 97kg/15st 4lb) who were enrolled in a weight management ...

The Hims & Hers wellness platform announced Wednesday it will soon offer a generic version of the weight loss drug ...

But the demand for semaglutide drugs — and especially Ozempic — has surged in Denmark and around the world due to their apparent weight-loss side effects, raising concerns among regulators ...

For the new study, Pottegård and his team analyzed data from 44,517 people in Denmark and 16,860 people in Norway, all of whom were eligible for semaglutide for the management of type 2 diabetes.

Results of the STEP 9 study in people with knee OA and obesity show that semaglutide not only induced significant weight loss but also improved knee pain and physical function.

Bagsværd, Denmark, 21 October 2024— Novo Nordisk today announced the headline results from the SOUL cardiovascular outcomes trial. The double-blinded, randomised trial compared oral semaglutide ...